Fierce BioBiotech
AACR: FDA vet Pazdur bemoans state of agency, warns of political influence and ‘sense of anxiety’
Summary
Asked by Fierce if he'd consider returning to the FDA, Pazdur said he wouldn't serve again under the Trump administration "for obvious reasons."
Asked by Fierce if he'd consider returning to the FDA, Pazdur said he wouldn't serve again under the Trump administration "for obvious reasons."